Mechanisms of inactivation of p14(ARF), p15(INK4b), and p16(INK4a) genes in human esophageal squamous cell carcinoma

Clinical Cancer Research

Volumn 5, Issue 10, 1999, Pages 2704-2713

  Xing, Eric Poe ^a   Nie, Yan ^a   Song, Yunlong ^a   Yang, Guang Yu ^a   Cai, Yuyang Christine ^a   Wang, Li Dong ^b   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MESSENGER RNA; ONCOPROTEIN; PROTEIN P15; PROTEIN P16; RETINOBLASTOMA PROTEIN; CALPONIN HOMOLOG PROTEIN, SCHISTOSOMA JAPONICUM; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; HELMINTH PROTEIN; MUSCLE PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CLINICAL ARTICLE; DNA METHYLATION; ESOPHAGUS CARCINOMA; GENE CLUSTER; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GENE MAPPING; GENE MUTATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; CHROMOSOME 9; CPG ISLAND; ESOPHAGUS TUMOR; GENETICS; MULTIGENE FAMILY; MUTATION; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 9; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; GENE DELETION; GENES, P16; GENES, TUMOR SUPPRESSOR; HELMINTH PROTEINS; HUMANS; MULTIGENE FAMILY; MUSCLE PROTEINS; MUTATION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0032589744     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
2. Carnero, A., and Hannon, G. J. The INK4 family of CDK inhibitors. Curr. Top. Microbiol. Immunol., 227: 43-55, 1998.
3. Stone, S., Jiang, P., Dayananth, P., Tavtigian, S. V., Katcher, H., Parry, D., Peters, G., and Kamb, A. Complex structure and regulation of the P16 (MTSI) locus. Cancer Res., 55: 2988-2994, 1995.
4. Quelle, D. E., Zindy, F., Ashmun, R. A., and Sherr, C. J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 83: 993-1000, 1995.
5. Hannon, G. J., and Beach, D. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest [see comments]. Nature (Lond.), 371: 257-261, 1994.
6. Cayuela, J. M., Gardie, B., and Sigaux, F. Disruption of the multiple tumor suppressor gene MTSI/p16(INK4a)/CDKN2 by illegitimate V(D)J recombinase activity in T-cell acute lymphoblastic leukemias. Blood, 90: 3720-3726, 1997.
7. Robertson, K. D., and Jones, P. A. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. Cell. Biol., 18: 6457-6473, 1998.
8. Chin, L., Pomerantz, J., and DePinho, R. A. The INK4a/ARF tumor suppressor: one gene-two products-two pathways. Trends Biochem. Sci., 23: 291-296, 1998.
9. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 [see comments]. Nature (Lond.), 366: 704-777, 1993.
10. Pomerantz, J., Schreiber-Agus, N., Liegeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H. W., Cordon-Cardo, C., and DePinho, R. A. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell, 92: 713-723, 1998.
11. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., and Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell, 88: 593-602, 1997.
12. Palmero, I., Pantoja, C., and Serrano, M. p19ARF links the tumour suppressor p53 to Ras. Nature (Lond.), 595: 125-126, 1998.
13. Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., and Vousden, K. H. p14ARF links the tumour suppressors RB and p53. Nature (Lond.), 395: 124-125, 1998.
14. Hirama, T., and Koeffler, H. P. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood, 86: 841-854, 1995.
15. Orlow, I., Lacombe, L., Hannon, G. J., Serrano, M., Pellicer, I., Dalbagni, G., Reuter, V. E., Zhang, Z. P., Beach, D., and Cordon-Cardo, C. Deletion of the p16 and p15 genes in human bladder tumors [see comments]. J. Natl. Cancer Inst., 87: 1524-1529, 1995.
16. Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, L., Buckler, A., Gabrielson, E., Tockman, M., Cho, K. R., Hedrick, L., Bova, G. S., Issacs, W., Koch, W., Schwab, D., and Sidransky, D. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet., 11: 210-212, 1995.
17. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J. P., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTSI gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4525-4530, 1995.
18. Herman, J. G., Civin, C. I., Issa, J. P., Collector, M. I., Sharkis, S. J., and Baylin, S. B. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res., 57: 837-841, 1997.
19. Pollock, P. M., Pearson, J. V., and Hayward, N. K. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer, 15: 77-88, 1996.
20. INK4b are frequent events in human esophageal cancer in Linxian, China. Carcinogenesis, 20: 77-84, 1999.
21. Gardie, B., Cayuela, J. M., Martini, S., and Sigaux, F. Genomic alterations of the p19ARF encoding exons in T-cell acute lymphoblastic leukemia. Blood, 91: 1016-1020, 1998.
22. Fukunaga, K. Statistical Pattern Recognition, Ed. 2. San Diego, CA: Academic Press, Inc., 1990.
23. Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., and Sherr, C. J. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell, 91: 649-659, 1997.
24. Kamb, A. Cyclin-dependent kinase inhibitors and human cancer. Curr. Top. Microbiol. Immunol., 227: 139-148, 1998.
25. Quelle, D. E., Cheng, M., Ashmun, R. A., and Sherr, C. J. Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF. Proc. Natl. Acad. Sci. USA, 94: 669-673, 1997.
26. Larsen, C. J. p16INK4a: a gene with a dual capacity to encode unrelated proteins that inhibit cell cycle progression. Oncogene, 12: 2041-2044, 1996.
27. Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R. A. Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85: 27-37, 1996.
28. Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., and Sherr, C. J. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. USA, 95: 8292-8297, 1998.
29. Sangfelt, O., Erickson, S., Einhorn, S., and Grander, D. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-α in hematopoietic cell lines. Oncogene, 14: 415-423, 1997.
30. Iravani, M., Dhat, R., and Price, C. M. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia. Oncogene, 15: 2609-2614, 1997.
31. Igaki, H., Sasaki, H., Tachimori, Y., Kato, H., Watanabe, H., Kimura, T., Harada, Y., Sugimura, T., and Terada, M. Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Res., 55: 3421-3423, 1995.
32. Maesawa, C., Tamura, G., Nishizuka, S., Ogasawara, S., Ishida, K., Terashima, M., Sakata, K., Sato, N., Saito, K., and Satodate, R. Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma. Cancer Res., 56: 3875-3878, 1996.
33. Chan, W. C., Tang, C. M., Lau, K. W., and Lung, M. L. p16 tumor suppressor gene mutations in Chinese esophageal carcinomas in Hong Kong. Cancer Lett., 115: 201-206, 1997.
34. Hayashi, K., Metzger, R., Salonga, D., Danenberg, K., Leichman, L. P., Fink, U., Sendler, A., Kelsen, D., Schwartz, G. K., Groshen, S., Lenz, H. J., and Danenberg, P. V. High frequency of simultaneous loss of p16 and p16β gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach. Oncogene, 15: 1481-1488, 1997.
35. Laird, P. W., and Jaenisch, R. The role of DNA methylation in cancer genetic and epigenetics. Annu. Rev. Genet., 30: 441-464, 1996.
36. Gonzalgo, M. L., Hayashida, T., Bender, C. M., Pao, M. M., Tsai, Y. C., Gonzales, F. A., Nguyen, H. D., Nguyen, T. T., and Jones, P. A. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer Res., 58: 1245-1252, 1998.